Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laura Melotti
Observed names:
L Melotti,
Melotti, Laura
Institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Bologna
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Bologna
ORCID:
0009-0003-9736-9030
Observed ORCID:
0009-0003-9736-9030
OpenAlex ID:
A5060011069
COVID-19 in IBD: The experience of a single tertiary IBD center
2020
·
Fernando Rizzello
, Carlo Calabrese
, et al.
·
Digestive and Liver Disease
·
45
PDF
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study
2024
·
Gabriele Dragoni
, Tommaso Innocenti
, et al.
·
The American Journal of Gastroenterology
·
21
Signatures of disease outcome severity in the intestinal fungal and bacterial microbiome of COVID-19 patients
2024
·
Fernando Rizzello
, Elisa Viciani
, et al.
·
Frontiers in Cellular and Infection Microbiology
·
7
PDF
P0591 Janus Kinase Inhibitors Improve Liver Biochemistry in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: an ECCO CONFER Study.
2025
·
A Soriano
, D Maggi
, et al.
·
Journal of Crohn s and Colitis
·
3
PDF
Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis?
2024
·
Laura Melotti
, Matteo Rinaldi
, et al.
·
Microbiology Spectrum
·
3
Real‐World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease—A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases ( IG ‐ IBD )
2026
·
Brigida Barberio
, Ferdinando D'Amico
, et al.
·
Alimentary Pharmacology & Therapeutics
·
2
PDF
From trial to real life: ten-year impact of a nutraceutical strategy on duodenal polyp burden in familial adenomatous polyposis
2026
·
Carlo Calabrese
, Nikolas Kostantine Dussias
, et al.
·
Frontiers in Oncology
·
2
PDF
DOP030 Real-world effectiveness and safety of mirikizumab in refractory, biologic-experienced ulcerative colitis patients
2026
·
L Melotti
, N Dussias
, et al.
·
Journal of Crohn s and Colitis
·
1
P0314 External validation of ultrasound scores for Crohn’s Disease: IBUS-SAS, BUSS, SUS-CD, Simple-US
2025
·
L Melotti
, N Dussias
, et al.
·
Journal of Crohn s and Colitis
·
1
The contribution of ultrasound in the diagnostic pathway of a symptomatic hepatocellular adenoma arising from ectopic liver
2024
·
Nicholas Vanigli
, Laura Melotti
, et al.
·
Journal of Ultrasound
·
1
P706 Monitoring asymptomatic patients with Crohn's disease: the role of intestinal ultrasound
2023
·
N Dussias
, L Melotti
, et al.
·
Journal of Crohn s and Colitis
·
1
PDF
Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn's disease
2022
·
Laura Melotti
, Nikolas Konstantine Dussias
, et al.
·
Digestive and Liver Disease
·
1
Effectiveness and safety of mirikizumab in multirefractory ulcerative colitis: analysis from a real-world cohort
2026
·
Laura Melotti
, Ottavia Monicelli
, et al.
·
Digestive and Liver Disease
PDF
Sa1547 INTESTINAL ULTRASOUND PREDICTS RELAPSE IN CROHN’S DISEASE DURING CLINICAL REMISSION
2026
·
Nikolas K. Dussias
, Laura Melotti
, et al.
·
Gastrointestinal Endoscopy
Sa1547 INTESTINAL ULTRASOUND PREDICTS RELAPSE IN CROHN’S DISEASE DURING CLINICAL REMISSION
2026
·
Nikolas K. Dussias
, Laura Melotti
, et al.
·
Gastroenterology
Evaluation of the Efficacy and Safety of a Nutraceutical Containing Sodium Alginate, Sodium Bicarbonate, PEA, A Blend of Opuntia Ficus Indica, and Olea Europaea, Musa Paradisiaca, and Ginger in Patients with NERD
2026
·
Carlo Calabrese
, Nikolas Konstantine Dussias
, et al.
·
Nutraceutical research.
Acnmd26-440: Effectiveness, Safety, and Persistence of Risankizumab in Biologic-experienced Crohn’s Disease Patients
2026
·
Pasquale Dragone
, Nikolas Konstantine Dussias
, et al.
·
Digestive and Liver Disease
P0884 Effectiveness, safety, and persistence of risankizumab in biologic-experienced Crohn’s disease patients
2026
·
N Dussias
, L Melotti
, et al.
·
Journal of Crohn s and Colitis
P0402 Intestinal ultrasound predicts relapse in Crohn’s disease during clinical remission
2026
·
N Dussias
, L Melotti
, et al.
·
Journal of Crohn s and Colitis
P0665 Long-term efficacy and dose intensification of ustekinumab in achieving clinical, laboratory, and endoscopic remission in Crohn’s disease
2025
·
N Dussias
, L Melotti
, et al.
·
Journal of Crohn s and Colitis
Su1849 CYTOMEGALOVIRUS COLITIS IN PATIENTS WITH MODERATE-TOSEVERE ULCERATIVE COLITIS: DIAGNOSIS, CLINICAL IMPACT AND TREATMENT EFFICACY
2024
·
Laura Melotti
, Marco Salice
, et al.
·
Gastroenterology
1175 Long Term Follow-up of Patients With Ulcerative Colitis After Withdrawl of Infliximab for Deep and Stable Remission
2024
·
Nikolas K. Dussias
, Laura Melotti
, et al.
·
Gastroenterology
Mo1782 MONITORING CROHN'S DISEASE PATIENTS IN CLINICAL REMISSION: THE ROLE OF INTESTINAL ULTRASOUND
2024
·
Nikolas K. Dussias
, Laura Melotti
, et al.
·
Gastroenterology
Show more works
View as search
Works count:
25
Citation count:
89
H-index:
3
I10-index:
2
Year
Topic
Type